N-Boc-N-bis(PEG4-OH) manufacturers
- N-Boc-N-bis(PEG4-OH)
-
-
2025-06-07
- CAS:2093154-02-8
- Min. Order: 500mg
- Purity: >95.00%
- Supply Ability: 500mg
|
| | N-Boc-N-bis(PEG4-OH) Basic information |
| Product Name: | N-Boc-N-bis(PEG4-OH) | | Synonyms: | N-Boc-N-bis(PEG4-OH);N-Boc-N-bis-PEG5;5,8,11,14-Tetraoxa-2-azahexadecanoic acid, 16-hydroxy-2-(14-hydroxy-3,6,9,12-tetraoxatetradec-1-yl)-, 1,1-dimethylethyl ester;BocN-(PEG5-OH)2;tert-Butyl bis(14-hydroxy-3,6,9,12-tetraoxatetradecyl)carbamate | | CAS: | 2093154-02-8 | | MF: | C25H51NO12 | | MW: | 557.67 | | EINECS: | | | Product Categories: | | | Mol File: | 2093154-02-8.mol |  |
| | N-Boc-N-bis(PEG4-OH) Chemical Properties |
| | N-Boc-N-bis(PEG4-OH) Usage And Synthesis |
| Description | N-Boc-N-bis(PEG4-OH) is a small PEG compound, the hydroxy groups can be derivatized or replaceedwith other reactive functional groups. N-Boc can be removed under acidic conditions | | Uses | N-Boc-N-bis-PEG5 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | N-Boc-N-bis(PEG4-OH) Preparation Products And Raw materials |
|